IOPAMIDOL

IOPAMIDOL was reported 2986 times

IOPAMIDOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CEREBRAL ARTERY STENT INSERTION 5 0.8333
1 EXPOSURE TO LEAD 2 0.2857
2 HEPATIC ARTERY STENOSIS 27 0.2077
3 RAPIDLY PROGRESSIVE OSTEOARTHRITIS 6 0.1395
4 CONTRAST ENCEPHALOPATHY 26 0.0942
5 HEPATIC ARTERY OCCLUSION 8 0.0941
6 CONTRAST MEDIA REACTION 145 0.0614
7 PERINEAL NECROSIS 2 0.0488
8 NEURODEVELOPMENTAL DELAY 2 0.0435
9 DIURETIC THERAPY 2 0.0278
10 CONTRAST MEDIA ALLERGY 46 0.0251
11 NIH STROKE SCALE SCORE INCREASED 2 0.0241
12 CONTRAST MEDIA TOXICITY 3 0.0236
13 STROKE IN EVOLUTION 5 0.0225
14 SPINAL CORD ISCHAEMIA 3 0.0197
15 ADHESIOLYSIS 2 0.0187
16 AGONAL RESPIRATION 5 0.0177
17 ANTI-THYROID ANTIBODY INCREASED 2 0.0159
18 HAEMOPHILUS TEST POSITIVE 2 0.0155
19 SCROTAL ABSCESS 5 0.0132
20 NECROTISING SOFT TISSUE INFECTION 3 0.0130
21 EXTRAVASATION 53 0.0129
22 ANAPHYLACTOID SHOCK 5 0.0106
23 IN-STENT CORONARY ARTERY RESTENOSIS 2 0.0104
24 DEAFNESS PERMANENT 2 0.0102
25 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 8 0.0097
26 ARTHRITIS ENTEROPATHIC 3 0.0092
27 MENINGITIS CHEMICAL 2 0.0091
28 SIALOADENITIS 12 0.0088
29 PRODUCT DEPOSIT 12 0.0077
30 GASTROINTESTINAL LYMPHOMA 2 0.0077
31 PROLONGED EXPIRATION 2 0.0076
32 GENITAL ABSCESS 3 0.0074
33 FISTULA OF SMALL INTESTINE 3 0.0072
34 IMMATURE GRANULOCYTE COUNT INCREASED 2 0.0071
35 LIP PRURITUS 6 0.0070
36 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG 2 0.0069
37 ASPIRATION BRONCHIAL 2 0.0068
38 TERMINAL ILEITIS 4 0.0065
39 ASPERGILLUS TEST POSITIVE 2 0.0065
40 ADENOCARCINOMA GASTRIC 6 0.0065
41 AIR EMBOLISM 3 0.0064
42 KOUNIS SYNDROME 14 0.0062
43 IODINE ALLERGY 2 0.0060
44 ALANINE AMINOTRANSFERASE DECREASED 4 0.0055
45 RESPIRATORY TRACT OEDEMA 4 0.0054
46 SKIN TEST POSITIVE 5 0.0054
47 LOWER RESPIRATORY TRACT INFECTION FUNGAL 2 0.0051
48 LIPOEDEMA 2 0.0051
49 ADMINISTRATION SITE EXTRAVASATION 5 0.0050
50 HYPOXIC ENCEPHALOPATHY 2 0.0049
51 ANAPHYLACTOID REACTION 20 0.0049
52 INJECTION RELATED REACTION 8 0.0048
53 HYPERCHLORAEMIA 3 0.0047
54 CARBON DIOXIDE DECREASED 5 0.0043
55 INFUSION SITE EXTRAVASATION 26 0.0042
56 CEREBRAL ARTERY STENOSIS 2 0.0041
57 POOR QUALITY DRUG ADMINISTERED 26 0.0040
58 PULSE ABSENT 19 0.0040
59 FOAMING AT MOUTH 8 0.0040
60 ORAL PRURITUS 9 0.0039
61 PROCEDURAL SITE REACTION 2 0.0038
62 HEART FAILURE WITH REDUCED EJECTION FRACTION 2 0.0037
63 METASTASES TO KIDNEY 2 0.0036
64 BRAIN SCAN ABNORMAL 2 0.0036
65 INTENTION TREMOR 2 0.0035
66 TONGUE PRURITUS 3 0.0035
67 ENANTHEMA 2 0.0035
68 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
69 ABDOMINAL LYMPHADENOPATHY 3 0.0035
70 ENDOCRINE OPHTHALMOPATHY 3 0.0035
71 ANAPHYLACTIC REACTION 186 0.0034
72 CORONARY ARTERY RESTENOSIS 2 0.0033
73 CERUMEN IMPACTION 3 0.0033
74 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 2 0.0033
75 BLOOD PRESSURE IMMEASURABLE 5 0.0033
76 HYPERAESTHESIA TEETH 4 0.0032
77 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 2 0.0030
78 ANAPHYLACTIC SHOCK 78 0.0030
79 EMBOLIC CEREBRAL INFARCTION 2 0.0030
80 NEPHROGENIC SYSTEMIC FIBROSIS 9 0.0030
81 TYPE IV HYPERSENSITIVITY REACTION 8 0.0029
82 BLADDER DYSFUNCTION 3 0.0029
83 PULSELESS ELECTRICAL ACTIVITY 12 0.0029
84 SNEEZING 64 0.0029
85 PERINEAL PAIN 2 0.0028
86 CRYOGLOBULINAEMIA 2 0.0028
87 MENINGITIS BACTERIAL 4 0.0028
88 INTRA-ABDOMINAL FLUID COLLECTION 5 0.0028
89 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
90 PERIRECTAL ABSCESS 3 0.0027
91 SACROILIITIS 5 0.0026
92 PRODUCT PHYSICAL ISSUE 53 0.0026
93 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
94 LIQUID PRODUCT PHYSICAL ISSUE 19 0.0026
95 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 67 0.0026
96 WRONG DRUG ADMINISTERED 23 0.0026
97 MYOPERICARDITIS 2 0.0026
98 GROIN ABSCESS 3 0.0025
99 CEREBRAL ARTERY EMBOLISM 3 0.0025
100 ERYTHRODERMIC PSORIASIS 2 0.0024
101 PARAPLEGIA 7 0.0024
102 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8 0.0024
103 ADRENAL MASS 2 0.0024
104 NEPHROPATHY TOXIC 27 0.0024
105 BODY TEMPERATURE FLUCTUATION 5 0.0024
106 OESOPHAGEAL VARICES HAEMORRHAGE 5 0.0023
107 PERIPHERAL NERVE INJURY 2 0.0023
108 HILAR LYMPHADENOPATHY 2 0.0023
109 HYPERLEUKOCYTOSIS 2 0.0023
110 BLOOD ALBUMIN INCREASED 2 0.0022
111 ANAEMIA OF CHRONIC DISEASE 2 0.0022
112 CARBON DIOXIDE INCREASED 3 0.0022
113 ESSENTIAL HYPERTENSION 4 0.0022
114 RASH MORBILLIFORM 6 0.0022
115 BONE CYST 2 0.0021
116 TONIC CONVULSION 3 0.0021
117 GASTROINTESTINAL WALL THICKENING 3 0.0020
118 INJECTION SITE NECROSIS 4 0.0020
119 LIVEDO RETICULARIS 4 0.0019
120 PHARYNGEAL PARAESTHESIA 3 0.0019
121 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
122 KIDNEY ENLARGEMENT 2 0.0018
123 OXYGEN THERAPY 3 0.0018
124 ACUTE RESPIRATORY FAILURE 35 0.0018
125 TROPONIN I INCREASED 3 0.0018
126 PRODUCT PACKAGE ASSOCIATED INJURY 4 0.0018
127 WRONG PRODUCT ADMINISTERED 12 0.0018
128 THROAT TIGHTNESS 48 0.0018
129 CHRONIC GASTRITIS 4 0.0018
130 GAZE PALSY 3 0.0018
131 INJECTION SITE OEDEMA 3 0.0017
132 ARTERIOSPASM CORONARY 7 0.0017
133 PO2 DECREASED 2 0.0017
134 CEREBRAL VENTRICLE DILATATION 2 0.0017
135 CHEMICAL BURN 2 0.0017
136 LUMBAR RADICULOPATHY 2 0.0017
137 NEPHROGENIC ANAEMIA 8 0.0017
138 PAROTITIS 2 0.0017
139 NECROTISING FASCIITIS 6 0.0017
140 INGROWING NAIL 4 0.0017
141 EMBOLISM ARTERIAL 2 0.0017
142 FEBRILE CONVULSION 2 0.0016
143 DUODENITIS 5 0.0016
144 UNRESPONSIVE TO STIMULI 42 0.0016
145 PHARYNGEAL OEDEMA 25 0.0016
146 PNEUMOPERITONEUM 3 0.0016
147 JOINT WARMTH 2 0.0016
148 NASAL PRURITUS 2 0.0016
149 LYMPHADENOPATHY MEDIASTINAL 3 0.0016
150 PORTAL VEIN THROMBOSIS 5 0.0015
151 CONVERSION DISORDER 3 0.0015
152 EARLY SATIETY 3 0.0015
153 EFFUSION 2 0.0015
154 ISCHAEMIC HEPATITIS 2 0.0015
155 MENINGITIS VIRAL 2 0.0015
156 INFUSION SITE RASH 2 0.0015
157 PLEURITIC PAIN 4 0.0014
158 VENTRICULAR FIBRILLATION 16 0.0014
159 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
160 THROAT IRRITATION 63 0.0014
161 OCCUPATIONAL EXPOSURE TO PRODUCT 9 0.0014
162 CEREBELLAR HAEMORRHAGE 2 0.0014
163 HYPERPHOSPHATAEMIA 3 0.0014
164 CARDIO-RESPIRATORY ARREST 57 0.0014
165 NORMOCYTIC ANAEMIA 2 0.0014
166 GENERALISED ANXIETY DISORDER 2 0.0014
167 STRIDOR 4 0.0014
168 FEAR OF DEATH 3 0.0013
169 METABOLIC ENCEPHALOPATHY 4 0.0013
170 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
171 INFECTIOUS PLEURAL EFFUSION 2 0.0013
172 CALCULUS URINARY 2 0.0013
173 MEAN CELL VOLUME DECREASED 2 0.0013
174 TOXIC SKIN ERUPTION 13 0.0013
175 HYPOAESTHESIA ORAL 19 0.0013
176 COLON CANCER METASTATIC 2 0.0012
177 THROMBOSIS IN DEVICE 4 0.0012
178 INTESTINAL POLYP 2 0.0012
179 DEAFNESS NEUROSENSORY 4 0.0012
180 CLOSTRIDIAL INFECTION 4 0.0012
181 BLOOD CHLORIDE DECREASED 3 0.0012
182 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 9 0.0012
183 COMPARTMENT SYNDROME 3 0.0011
184 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
185 RIGHT VENTRICULAR FAILURE 8 0.0011
186 URTICARIA 191 0.0011
187 SPINAL OSTEOARTHRITIS 10 0.0011
188 GASTROINTESTINAL OEDEMA 2 0.0011
189 LUNG TRANSPLANT 4 0.0011
190 MITRAL VALVE DISEASE 2 0.0011
191 PROTEIN TOTAL INCREASED 3 0.0011
192 PNEUMONIA KLEBSIELLA 2 0.0011
193 UROSEPSIS 10 0.0011
194 LUNG CONSOLIDATION 3 0.0011
195 HAEMODIALYSIS 9 0.0011
196 ADENOCARCINOMA OF COLON 2 0.0011
197 SKIN HYPERTROPHY 3 0.0011
198 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
199 HYPOVOLAEMIA 6 0.0010
200 NASAL SEPTUM DEVIATION 2 0.0010
201 RENAL TUBULAR NECROSIS 10 0.0010
202 HYPERAEMIA 2 0.0010
203 SKIN LACERATION 11 0.0010
204 ISCHAEMIC STROKE 18 0.0010
205 ABDOMINAL TENDERNESS 5 0.0010
206 CORONARY ARTERY STENOSIS 5 0.0010
207 EMBOLISM VENOUS 3 0.0010
208 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
209 FIBROSIS 3 0.0010
210 CHANGE OF BOWEL HABIT 2 0.0010
211 LARYNGEAL OEDEMA 6 0.0010
212 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
213 INJECTION SITE EXTRAVASATION 12 0.0010
214 BLOOD LACTIC ACID INCREASED 5 0.0009
215 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
216 PURULENT DISCHARGE 4 0.0009
217 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
218 LANGUAGE DISORDER 2 0.0009
219 PYELONEPHRITIS 8 0.0009
220 HENOCH-SCHONLEIN PURPURA 2 0.0009
221 PROCEDURAL COMPLICATION 7 0.0009
222 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
223 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
224 TORSADE DE POINTES 7 0.0009
225 ACUTE PULMONARY OEDEMA 5 0.0009
226 WOUND DEHISCENCE 3 0.0009
227 METASTASES TO MENINGES 2 0.0009
228 PERIARTHRITIS 2 0.0009
229 CARDIAC ARREST 72 0.0009
230 RESPIRATORY ARREST 24 0.0009
231 TYPE I HYPERSENSITIVITY 3 0.0009
232 PARAESTHESIA ORAL 12 0.0008
233 INJECTION SITE VESICLES 5 0.0008
234 HYPOXIA 29 0.0008
235 PHARYNGEAL SWELLING 8 0.0008
236 PRODUCT CONTAINER ISSUE 7 0.0008
237 ANURIA 7 0.0008
238 MULTI-ORGAN FAILURE 14 0.0008
239 ANEURYSM 4 0.0008
240 URINE OUTPUT DECREASED 7 0.0008
241 THROAT CLEARING 3 0.0008
242 NO ADVERSE EVENT 145 0.0008
243 PROTEIN TOTAL DECREASED 3 0.0008
244 CONTRAINDICATED PRODUCT ADMINISTERED 24 0.0008
245 BRAIN OEDEMA 10 0.0008
246 DYSPHORIA 4 0.0008
247 RESPIRATORY RATE INCREASED 7 0.0008
248 ABNORMAL UTERINE BLEEDING 2 0.0008
249 MEAN CELL VOLUME INCREASED 2 0.0008
250 HEPATOSPLENOMEGALY 2 0.0008
251 AORTIC ARTERIOSCLEROSIS 2 0.0008
252 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
253 OROPHARYNGEAL DISCOMFORT 7 0.0008
254 HIATUS HERNIA 10 0.0008
255 HYPOALBUMINAEMIA 6 0.0008
256 RHINOVIRUS INFECTION 3 0.0008
257 APNOEA 6 0.0008
258 ACTINIC KERATOSIS 2 0.0008
259 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
260 CYANOSIS 12 0.0008
261 PNEUMONIA FUNGAL 3 0.0008
262 ACUTE KIDNEY INJURY 116 0.0008
263 CEREBRAL ATROPHY 3 0.0008
264 CARDIAC FAILURE ACUTE 5 0.0007
265 ABDOMINAL MASS 2 0.0007
266 ANAL ABSCESS 4 0.0007
267 NEUROTOXICITY 13 0.0007
268 POSTOPERATIVE WOUND INFECTION 5 0.0007
269 ABDOMINAL RIGIDITY 2 0.0007
270 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
271 PERIPHERAL ISCHAEMIA 3 0.0007
272 ARTHRITIS BACTERIAL 3 0.0007
273 OXYGEN SATURATION DECREASED 41 0.0007
274 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
275 CHOKING SENSATION 4 0.0007
276 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
277 EOSINOPHIL COUNT INCREASED 6 0.0007
278 MATERNAL EXPOSURE DURING PREGNANCY 64 0.0007
279 ENDOTRACHEAL INTUBATION 2 0.0007
280 ABSCESS LIMB 3 0.0007
281 GENERALISED ERYTHEMA 4 0.0007
282 OESOPHAGEAL STENOSIS 2 0.0007
283 PANCREATIC CARCINOMA METASTATIC 2 0.0007
284 ANGIOEDEMA 31 0.0007
285 SHOCK 16 0.0007
286 DIVERTICULUM INTESTINAL 3 0.0007
287 LUMBAR SPINAL STENOSIS 2 0.0007
288 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
289 RENAL INJURY 20 0.0007
290 MENINGITIS ASEPTIC 3 0.0007
291 ANAL INCONTINENCE 6 0.0007
292 LEUKOCYTOSIS 12 0.0007
293 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
294 MYELOFIBROSIS 2 0.0007
295 ABDOMINAL HERNIA 3 0.0007
296 LIPASE INCREASED 5 0.0007
297 DYSAESTHESIA 2 0.0007
298 RESPIRATORY DISTRESS 18 0.0007
299 INTRACARDIAC THROMBUS 2 0.0007
300 SMALL INTESTINAL OBSTRUCTION 8 0.0006
301 LOCALISED OEDEMA 3 0.0006
302 DIASTOLIC DYSFUNCTION 2 0.0006
303 ARTHRITIS INFECTIVE 3 0.0006
304 OLIGURIA 4 0.0006
305 ERYTHEMA MULTIFORME 6 0.0006
306 NEPHROPATHY 6 0.0006
307 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
308 FLANK PAIN 6 0.0006
309 SKIN TIGHTNESS 3 0.0006
310 AFFECTIVE DISORDER 5 0.0006
311 INFUSION SITE PRURITUS 2 0.0006
312 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
313 NON-CARDIAC CHEST PAIN 2 0.0006
314 BLOOD ALBUMIN DECREASED 5 0.0006
315 BILE DUCT STONE 2 0.0006
316 ORTHOPNOEA 2 0.0006
317 PNEUMONIA VIRAL 2 0.0006
318 CUSHINGOID 2 0.0006
319 SENSORY LOSS 5 0.0006
320 LOOSE TOOTH 2 0.0006
321 ANGINA UNSTABLE 4 0.0006
322 HEPATITIS ACUTE 4 0.0006
323 FACET JOINT SYNDROME 2 0.0006
324 HYPOVENTILATION 2 0.0006
325 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
326 BREATH SOUNDS ABNORMAL 3 0.0006
327 VENTRICULAR TACHYCARDIA 10 0.0006
328 PULMONARY MASS 9 0.0006
329 PEPTIC ULCER 2 0.0006
330 ASPARTATE AMINOTRANSFERASE INCREASED 32 0.0006
331 HYPERNATRAEMIA 3 0.0006
332 POST-TRAUMATIC STRESS DISORDER 4 0.0006
333 METASTASES TO SPINE 2 0.0006
334 SENSATION OF FOREIGN BODY 5 0.0006
335 HYPERSENSITIVITY 110 0.0006
336 BACTERAEMIA 7 0.0006
337 MOTOR DYSFUNCTION 6 0.0006
338 TRANSAMINASES INCREASED 13 0.0006
339 EYE MOVEMENT DISORDER 4 0.0006
340 SKIN HYPERPIGMENTATION 5 0.0006
341 DROOLING 4 0.0006
342 VENTRICULAR EXTRASYSTOLES 6 0.0006
343 ADRENAL INSUFFICIENCY 7 0.0006
344 PRESYNCOPE 14 0.0006
345 HYPOMAGNESAEMIA 8 0.0006
346 EAR PRURITUS 2 0.0006
347 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
348 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
349 DUODENAL ULCER 4 0.0006
350 SINUS TACHYCARDIA 8 0.0006
351 PRODUCT CONTAMINATION 2 0.0006
352 HAEMORRHAGIC DIATHESIS 2 0.0006
353 CARDIOGENIC SHOCK 8 0.0006
354 BLOOD CREATININE INCREASED 36 0.0006
355 CAROTID ARTERY OCCLUSION 2 0.0005
356 SWOLLEN TONGUE 17 0.0005
357 ASCITES 16 0.0005
358 BLOOD PRESSURE DECREASED 36 0.0005
359 GASTRIC ULCER HAEMORRHAGE 3 0.0005
360 ANGIOPATHY 3 0.0005
361 HYDRONEPHROSIS 4 0.0005
362 CEREBRAL INFARCTION 13 0.0005
363 PULMONARY CONGESTION 7 0.0005
364 CHOLECYSTITIS ACUTE 3 0.0005
365 ADVERSE REACTION 7 0.0005
366 FACE INJURY 2 0.0005
367 TROPONIN INCREASED 4 0.0005
368 HAEMODYNAMIC INSTABILITY 4 0.0005
369 ACIDOSIS 4 0.0005
370 HYPOKALAEMIA 24 0.0005
371 ENTEROCOLITIS 3 0.0005
372 ATELECTASIS 5 0.0005
373 SKIN WARM 3 0.0005
374 TACHYPNOEA 7 0.0005
375 RENAL CYST 4 0.0005
376 HYPERLIPIDAEMIA 6 0.0005
377 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
378 GANGRENE 3 0.0005
379 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
380 CYSTITIS HAEMORRHAGIC 2 0.0005
381 STEVENS-JOHNSON SYNDROME 11 0.0005
382 NOCTURIA 6 0.0005
383 END STAGE RENAL DISEASE 9 0.0005
384 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
385 BRONCHOSPASM 7 0.0005
386 ASPHYXIA 4 0.0005
387 PERIPHERAL VENOUS DISEASE 2 0.0005
388 GENERALISED OEDEMA 6 0.0005
389 SCOLIOSIS 3 0.0005
390 SEPSIS 54 0.0005
391 CHOLANGITIS 3 0.0005
392 AORTIC DISSECTION 2 0.0005
393 CHEST DISCOMFORT 49 0.0005
394 BLOOD UREA INCREASED 8 0.0005
395 HALLUCINATIONS, MIXED 2 0.0005
396 URINARY INCONTINENCE 14 0.0005
397 HYPERPYREXIA 2 0.0005
398 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
399 HEMIPARESIS 8 0.0005
400 RENAL FAILURE ACUTE 20 0.0005
401 FACIAL PARALYSIS 4 0.0005
402 ENTERITIS 3 0.0005
403 HAEMORRHAGE INTRACRANIAL 7 0.0005
404 PROCTALGIA 3 0.0005
405 APHASIA 14 0.0005
406 INCOHERENT 3 0.0005
407 BONE CANCER 2 0.0005
408 ANHEDONIA 12 0.0005
409 ALANINE AMINOTRANSFERASE INCREASED 28 0.0005
410 GINGIVAL SWELLING 2 0.0005
411 PRURITUS 174 0.0005
412 PHYSICAL DISABILITY 2 0.0005
413 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
414 PURPURA 4 0.0005
415 DRUG ERUPTION 8 0.0005
416 RASH MACULO-PAPULAR 10 0.0004
417 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
418 CYTOKINE RELEASE SYNDROME 9 0.0004
419 ENCEPHALOPATHY 11 0.0004
420 INCORRECT ROUTE OF DRUG ADMINISTRATION 16 0.0004
421 INTESTINAL PERFORATION 5 0.0004
422 IRON DEFICIENCY 2 0.0004
423 RENAL FAILURE 59 0.0004
424 PALLOR 12 0.0004
425 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
426 HAEMATURIA 15 0.0004
427 PNEUMONIA BACTERIAL 4 0.0004
428 ISCHAEMIA 2 0.0004
429 CHRONIC KIDNEY DISEASE 33 0.0004
430 MENTAL STATUS CHANGES 12 0.0004
431 FORMICATION 3 0.0004
432 EYELID OEDEMA 5 0.0004
433 DIARRHOEA HAEMORRHAGIC 4 0.0004
434 SPINAL PAIN 5 0.0004
435 METASTASIS 3 0.0004
436 CHOLECYSTITIS 5 0.0004
437 ERYTHEMA 86 0.0004
438 POST PROCEDURAL COMPLICATION 8 0.0004
439 TONGUE DISORDER 3 0.0004
440 SINUS BRADYCARDIA 4 0.0004
441 FLUID OVERLOAD 6 0.0004
442 CIRCULATORY COLLAPSE 7 0.0004
443 PLEURAL EFFUSION 25 0.0004
444 UTERINE LEIOMYOMA 3 0.0004
445 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
446 FEELING HOT 25 0.0004
447 ACUTE MYOCARDIAL INFARCTION 12 0.0004
448 BLINDNESS TRANSIENT 3 0.0004
449 THERAPY CHANGE 4 0.0004
450 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
451 HYPOPHOSPHATAEMIA 3 0.0004
452 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
453 DIABETIC NEUROPATHY 2 0.0004
454 FLUSHING 41 0.0004
455 DERMATITIS EXFOLIATIVE 2 0.0004
456 BRADYCARDIA 21 0.0004
457 LYMPHADENOPATHY 14 0.0004
458 FEELING COLD 11 0.0004
459 HYPOPHAGIA 10 0.0004
460 DRUG ADMINISTRATION ERROR 12 0.0004
461 FEMORAL NECK FRACTURE 2 0.0004
462 PRODUCT COLOUR ISSUE 2 0.0004
463 CACHEXIA 2 0.0004
464 TEMPERATURE INTOLERANCE 4 0.0004
465 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
466 FAILURE TO THRIVE 2 0.0004
467 PERIORBITAL OEDEMA 2 0.0004
468 TENDERNESS 4 0.0004
469 PULMONARY OEDEMA 17 0.0004
470 IMMUNE SYSTEM DISORDER 5 0.0004
471 PNEUMOTHORAX 6 0.0004
472 TRICUSPID VALVE INCOMPETENCE 3 0.0004
473 HEPATIC STEATOSIS 7 0.0004
474 CHILLS 44 0.0004
475 PHOTOPHOBIA 7 0.0004
476 FEAR 10 0.0004
477 PRODUCT RESIDUE PRESENT 2 0.0004
478 GINGIVITIS 2 0.0004
479 HYPOCALCAEMIA 7 0.0004
480 PHARYNGITIS STREPTOCOCCAL 4 0.0004
481 DECUBITUS ULCER 3 0.0004
482 IMPAIRED GASTRIC EMPTYING 5 0.0004
483 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
484 ASPIRATION 4 0.0004
485 DENTAL CARIES 4 0.0004
486 HEMIPLEGIA 3 0.0004
487 LIP SWELLING 12 0.0004
488 INTRACRANIAL PRESSURE INCREASED 2 0.0004
489 ABDOMINAL PAIN LOWER 9 0.0004
490 WHEEZING 21 0.0004
491 COLECTOMY 2 0.0004
492 BLOOD PRESSURE ABNORMAL 7 0.0004
493 LOSS OF CONSCIOUSNESS 45 0.0004
494 GRANULOCYTOPENIA 2 0.0004
495 DERMATITIS CONTACT 4 0.0004
496 SCAR 6 0.0004
497 EYE SWELLING 13 0.0003
498 HYPOTENSION 70 0.0003
499 SKIN ULCER 9 0.0003
500 CARDIAC MURMUR 3 0.0003
501 MOUTH SWELLING 2 0.0003
502 BLOOD URIC ACID INCREASED 2 0.0003
503 HYSTERECTOMY 3 0.0003
504 PERICARDIAL EFFUSION 8 0.0003
505 SKIN SWELLING 3 0.0003
506 HYPERTHYROIDISM 5 0.0003
507 ELECTROLYTE IMBALANCE 4 0.0003
508 RESPIRATORY FAILURE 25 0.0003
509 MEDICATION ERROR 19 0.0003
510 NIGHT SWEATS 11 0.0003
511 METASTASES TO LIVER 6 0.0003
512 TUMOUR LYSIS SYNDROME 3 0.0003
513 LUNG INFILTRATION 3 0.0003
514 LYMPHOCYTE COUNT DECREASED 6 0.0003
515 DYSPNOEA 192 0.0003
516 COVID-19 PNEUMONIA 4 0.0003
517 IMMUNODEFICIENCY 5 0.0003
518 LUPUS-LIKE SYNDROME 3 0.0003
519 PELVIC PAIN 6 0.0003
520 SYNCOPE 33 0.0003
521 BURSITIS 4 0.0003
522 DERMATITIS ACNEIFORM 2 0.0003
523 EXOSTOSIS 3 0.0003
524 EYE PRURITUS 11 0.0003
525 DYSPHAGIA 31 0.0003
526 RESPIRATORY DEPRESSION 4 0.0003
527 MENISCUS INJURY 2 0.0003
528 CARDIOMEGALY 4 0.0003
529 DYSPHONIA 19 0.0003
530 BLOOD GLUCOSE ABNORMAL 6 0.0003
531 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
532 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
533 CHEST PAIN 60 0.0003
534 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
535 SEPTIC SHOCK 14 0.0003
536 APPENDICITIS 3 0.0003
537 NASAL DRYNESS 2 0.0003
538 INFUSION SITE SWELLING 2 0.0003
539 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
540 BLEPHAROSPASM 2 0.0003
541 BURNING SENSATION 22 0.0003
542 HYPERCHOLESTEROLAEMIA 3 0.0003
543 PRESCRIBED OVERDOSE 6 0.0003
544 ATRIAL FIBRILLATION 30 0.0003
545 POLYP 2 0.0003
546 METASTASES TO BONE 5 0.0003
547 OSTEONECROSIS 10 0.0003
548 HAEMATOCRIT DECREASED 6 0.0003
549 CORONAVIRUS INFECTION 2 0.0003
550 OVARIAN CYST 3 0.0003
551 LACRIMATION INCREASED 9 0.0003
552 CELLULITIS 15 0.0003
553 PERICARDITIS 5 0.0003
554 FACE OEDEMA 5 0.0003
555 METASTASES TO LYMPH NODES 2 0.0003
556 TOOTH ABSCESS 3 0.0003
557 NEUTROPHIL COUNT INCREASED 3 0.0003
558 POOR VENOUS ACCESS 3 0.0003
559 HYPERBILIRUBINAEMIA 3 0.0003
560 NASAL CONGESTION 17 0.0003
561 LYMPHOEDEMA 2 0.0003
562 COUGH 81 0.0003
563 HYPERTRANSAMINASAEMIA 2 0.0003
564 LOCAL SWELLING 5 0.0003
565 DEFAECATION URGENCY 2 0.0003
566 INCONTINENCE 3 0.0003
567 OSTEOARTHRITIS 12 0.0003
568 PRODUCT SUPPLY ISSUE 2 0.0003
569 CONVULSION 16 0.0003
570 DISCOMFORT 17 0.0003
571 IMPAIRED QUALITY OF LIFE 4 0.0003
572 PRURITUS GENERALISED 6 0.0003
573 PANIC REACTION 2 0.0003
574 SEIZURE 32 0.0003
575 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
576 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
577 FAECES SOFT 2 0.0003
578 RENAL IMPAIRMENT 23 0.0003
579 RESTLESSNESS 10 0.0003
580 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
581 SKIN DISORDER 9 0.0003
582 HYPERTENSIVE CRISIS 3 0.0003
583 HEPATIC FAILURE 8 0.0003
584 BLOOD SODIUM DECREASED 5 0.0003
585 CORONARY ARTERY DISEASE 8 0.0003
586 HYPERHIDROSIS 34 0.0003
587 COLITIS 10 0.0003
588 VOMITING 124 0.0003
589 MYOCARDIAL ISCHAEMIA 3 0.0003
590 OSTEOPENIA 4 0.0003
591 MICTURITION URGENCY 3 0.0003
592 HYPERTHERMIA 2 0.0003
593 SWELLING FACE 17 0.0003
594 DEVICE RELATED INFECTION 4 0.0003
595 METASTASES TO LUNG 3 0.0003
596 DELIRIUM 9 0.0003
597 FOOD ALLERGY 2 0.0003
598 HAEMOLYSIS 2 0.0003
599 ATRIOVENTRICULAR BLOCK 2 0.0003
600 MUSCULOSKELETAL CHEST PAIN 4 0.0003
601 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
602 CAESAREAN SECTION 3 0.0003
603 EAR PAIN 5 0.0003
604 HEART RATE DECREASED 9 0.0003
605 CHOKING 5 0.0003
606 HAEMORRHAGIC STROKE 2 0.0003
607 SPLENOMEGALY 3 0.0003
608 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
609 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
610 LOW BIRTH WEIGHT BABY 2 0.0003
611 ULCER 4 0.0003
612 CEREBRAL HAEMORRHAGE 9 0.0003
613 PRODUCTIVE COUGH 12 0.0003
614 GINGIVAL PAIN 2 0.0003
615 MYASTHENIA GRAVIS 2 0.0002
616 HYPERGLYCAEMIA 9 0.0002
617 MUSCLE TIGHTNESS 4 0.0002
618 POST PROCEDURAL INFECTION 2 0.0002
619 POLYURIA 2 0.0002
620 HYPERAESTHESIA 2 0.0002
621 PRODUCT PREPARATION ERROR 5 0.0002
622 STAPHYLOCOCCAL INFECTION 8 0.0002
623 PNEUMONIA ASPIRATION 6 0.0002
624 COAGULOPATHY 4 0.0002
625 PULMONARY HYPERTENSION 5 0.0002
626 RHABDOMYOLYSIS 10 0.0002
627 SECRETION DISCHARGE 3 0.0002
628 INTESTINAL OBSTRUCTION 9 0.0002
629 UNEVALUABLE EVENT 18 0.0002
630 HALLUCINATION, VISUAL 5 0.0002
631 HAEMATEMESIS 6 0.0002
632 EATING DISORDER 5 0.0002
633 INTRAOCULAR PRESSURE INCREASED 3 0.0002
634 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
635 MYDRIASIS 3 0.0002
636 ANOREXIA 3 0.0002
637 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
638 BLOOD MAGNESIUM DECREASED 2 0.0002
639 MUSCLE STRAIN 2 0.0002
640 PLATELET COUNT INCREASED 3 0.0002
641 AMENORRHOEA 4 0.0002
642 GROIN PAIN 2 0.0002
643 INJURY 16 0.0002
644 INFUSION RELATED REACTION 15 0.0002
645 TACHYCARDIA 20 0.0002
646 FACIAL PAIN 2 0.0002
647 QUALITY OF LIFE DECREASED 3 0.0002
648 ABDOMINAL PAIN 52 0.0002
649 MYOSITIS 2 0.0002
650 BLOOD BILIRUBIN INCREASED 6 0.0002
651 HYPOAESTHESIA 33 0.0002
652 HIDRADENITIS 2 0.0002
653 METABOLIC ACIDOSIS 7 0.0002
654 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
655 INCREASED TENDENCY TO BRUISE 2 0.0002
656 DYSURIA 8 0.0002
657 PROCEDURAL PAIN 6 0.0002
658 MASS 3 0.0002
659 CARPAL TUNNEL SYNDROME 3 0.0002
660 DEFORMITY 2 0.0002
661 CHOLELITHIASIS 7 0.0002
662 IMPAIRED HEALING 7 0.0002
663 PAIN IN JAW 6 0.0002
664 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
665 PYREXIA 73 0.0002
666 PROTEINURIA 4 0.0002
667 PARALYSIS 3 0.0002
668 BLOOD PRESSURE INCREASED 32 0.0002
669 NAUSEA 165 0.0002
670 MYELODYSPLASTIC SYNDROME 3 0.0002
671 COELIAC DISEASE 2 0.0002
672 CARDIOMYOPATHY 3 0.0002
673 DEHYDRATION 27 0.0002
674 DISABILITY 4 0.0002
675 RESPIRATORY DISORDER 6 0.0002
676 HYPOTONIA 2 0.0002
677 RASH MACULAR 7 0.0002
678 HYPERKALAEMIA 7 0.0002
679 EMPHYSEMA 2 0.0002
680 ECONOMIC PROBLEM 3 0.0002
681 TASTE DISORDER 4 0.0002
682 EPILEPSY 6 0.0002
683 SKIN DISCOLOURATION 9 0.0002
684 HYPONATRAEMIA 11 0.0002
685 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
686 RIB FRACTURE 4 0.0002
687 ANKLE FRACTURE 3 0.0002
688 TENDONITIS 3 0.0002
689 DIPLOPIA 5 0.0002
690 BASAL CELL CARCINOMA 3 0.0002
691 HEART RATE INCREASED 19 0.0002
692 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
693 GASTRITIS 5 0.0002
694 EMOTIONAL DISTRESS 23 0.0002
695 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
696 JOINT DISLOCATION 2 0.0002
697 FULL BLOOD COUNT ABNORMAL 2 0.0002
698 ABSCESS 3 0.0002
699 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
700 IRRITABLE BOWEL SYNDROME 4 0.0002
701 LIVER FUNCTION TEST INCREASED 4 0.0002
702 DYSARTHRIA 7 0.0002
703 DYSPNOEA EXERTIONAL 7 0.0002
704 MUSCULAR WEAKNESS 21 0.0002
705 PNEUMONITIS 5 0.0002
706 OESOPHAGITIS 2 0.0002
707 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
708 FEBRILE NEUTROPENIA 12 0.0002
709 VERTIGO 11 0.0002
710 DIVERTICULITIS 5 0.0002
711 NERVE INJURY 2 0.0002
712 MALNUTRITION 2 0.0002
713 DIZZINESS 89 0.0002
714 PANCREATITIS ACUTE 4 0.0002
715 FISTULA 2 0.0002
716 BLOOD CALCIUM DECREASED 2 0.0002
717 RED BLOOD CELL COUNT DECREASED 5 0.0002
718 RASH 76 0.0002
719 NEOPLASM 2 0.0002
720 POST PROCEDURAL HAEMORRHAGE 2 0.0002
721 SWELLING 16 0.0002
722 COLD SWEAT 3 0.0002
723 ANXIETY 48 0.0002
724 OCULAR HYPERAEMIA 8 0.0002
725 BLOOD IRON DECREASED 2 0.0002
726 POLLAKIURIA 7 0.0002
727 MYOCLONUS 2 0.0002
728 BLOOD POTASSIUM DECREASED 5 0.0002
729 OEDEMA 9 0.0002
730 TOOTHACHE 3 0.0002
731 OSTEOMYELITIS 3 0.0002
732 RESTLESS LEGS SYNDROME 3 0.0002
733 MYALGIA 28 0.0002
734 NEURALGIA 4 0.0002
735 ABDOMINAL DISTENSION 17 0.0002
736 ANAEMIA 31 0.0002
737 HYPERCALCAEMIA 2 0.0002
738 CARDIAC FAILURE CONGESTIVE 13 0.0002
739 HYPERTENSION 34 0.0002
740 CONSTIPATION 35 0.0002
741 DERMATITIS ALLERGIC 2 0.0002
742 HEAD INJURY 5 0.0002
743 GASTRIC CANCER 4 0.0002
744 MUSCLE ATROPHY 2 0.0002
745 EYE IRRITATION 9 0.0002
746 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
747 INFUSION SITE PAIN 2 0.0002
748 RASH GENERALISED 4 0.0002
749 LACTIC ACIDOSIS 5 0.0002
750 PALPITATIONS 18 0.0002
751 NODULE 2 0.0002
752 TINNITUS 7 0.0002
753 DISORIENTATION 6 0.0002
754 PANCREATITIS 8 0.0002
755 DECREASED APPETITE 35 0.0002
756 TREMOR 25 0.0002
757 CARDIAC FAILURE 12 0.0001
758 MALIGNANT MELANOMA 2 0.0001
759 JOINT RANGE OF MOTION DECREASED 2 0.0001
760 PRODUCT QUALITY ISSUE 20 0.0001
761 NEUTROPHIL COUNT DECREASED 6 0.0001
762 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
763 RASH ERYTHEMATOUS 7 0.0001
764 ORAL DISCOMFORT 2 0.0001
765 HAEMOPTYSIS 4 0.0001
766 NECK PAIN 8 0.0001
767 WOUND 4 0.0001
768 BLISTER 8 0.0001
769 MOUTH ULCERATION 3 0.0001
770 DEVICE OCCLUSION 2 0.0001
771 DIALYSIS 2 0.0001
772 RETCHING 3 0.0001
773 ARTHRITIS 11 0.0001
774 RECTAL HAEMORRHAGE 6 0.0001
775 ANGINA PECTORIS 4 0.0001
776 AMNESIA 9 0.0001
777 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
778 LIVER FUNCTION TEST ABNORMAL 4 0.0001
779 GASTROENTERITIS 2 0.0001
780 HAEMOGLOBIN DECREASED 14 0.0001
781 ASTHENIA 51 0.0001
782 LIVER DISORDER 6 0.0001
783 HEPATIC FUNCTION ABNORMAL 5 0.0001
784 SPEECH DISORDER 7 0.0001
785 PARAESTHESIA 21 0.0001
786 THERAPY NON-RESPONDER 6 0.0001
787 BACK PAIN 31 0.0001
788 CHROMATURIA 3 0.0001
789 HEART RATE IRREGULAR 3 0.0001
790 MUSCLE TWITCHING 3 0.0001
791 OROPHARYNGEAL PAIN 12 0.0001
792 EJECTION FRACTION DECREASED 2 0.0001
793 NERVOUS SYSTEM DISORDER 4 0.0001
794 PRODUCT USE COMPLAINT 2 0.0001
795 COMA 6 0.0001
796 OBESITY 2 0.0001
797 HYPOTHYROIDISM 4 0.0001
798 DIABETIC KETOACIDOSIS 3 0.0001
799 CONTUSION 12 0.0001
800 HIP FRACTURE 4 0.0001
801 THROMBOSIS 10 0.0001
802 CONFUSIONAL STATE 20 0.0001
803 EXTRA DOSE ADMINISTERED 5 0.0001
804 FIBROMYALGIA 3 0.0001
805 BLOOD POTASSIUM INCREASED 2 0.0001
806 LIVER INJURY 3 0.0001
807 MULTIPLE FRACTURES 2 0.0001
808 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
809 EXPIRED PRODUCT ADMINISTERED 4 0.0001
810 INJECTION SITE SWELLING 9 0.0001
811 HEPATITIS 3 0.0001
812 MUSCULOSKELETAL DISCOMFORT 2 0.0001
813 PULMONARY EMBOLISM 11 0.0001
814 NIGHTMARE 4 0.0001
815 ORTHOSTATIC HYPOTENSION 2 0.0001
816 NERVOUSNESS 6 0.0001
817 MUSCULOSKELETAL PAIN 6 0.0001
818 EOSINOPHILIA 2 0.0001
819 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
820 HEAD DISCOMFORT 2 0.0001
821 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
822 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
823 EXPOSURE DURING PREGNANCY 7 0.0001
824 PAIN 69 0.0001
825 OFF LABEL USE 98 0.0001
826 MOBILITY DECREASED 8 0.0001
827 RASH PRURITIC 6 0.0001
828 PERIPHERAL SWELLING 17 0.0001
829 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
830 C-REACTIVE PROTEIN INCREASED 4 0.0001
831 PANIC ATTACK 4 0.0001
832 SKIN LESION 3 0.0001
833 PRODUCT USE IN UNAPPROVED INDICATION 27 0.0001
834 ADVERSE EVENT 10 0.0001
835 AGRANULOCYTOSIS 2 0.0001
836 HEPATIC CIRRHOSIS 2 0.0001
837 CEREBROVASCULAR ACCIDENT 18 0.0001
838 GASTRIC ULCER 2 0.0001
839 HAEMORRHAGE 11 0.0001
840 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
841 HEADACHE 65 0.0001
842 ERUCTATION 2 0.0001
843 PLATELET COUNT DECREASED 11 0.0001
844 MYOCARDIAL INFARCTION 18 0.0001
845 HEPATIC ENZYME INCREASED 7 0.0001
846 HAEMORRHOIDS 2 0.0001
847 BONE PAIN 6 0.0001
848 DYSPEPSIA 10 0.0001
849 ARTHRALGIA 42 0.0001
850 DRUG INTERACTION 16 0.0001
851 GASTROINTESTINAL DISORDER 9 0.0001
852 WEIGHT DECREASED 28 0.0001
853 PREMATURE BABY 3 0.0001
854 GAIT DISTURBANCE 19 0.0001
855 PRODUCT ADMINISTRATION ERROR 2 0.0001
856 FEEDING DISORDER 2 0.0001
857 EMOTIONAL DISORDER 3 0.0001
858 OSTEOPOROSIS 4 0.0001
859 FEMUR FRACTURE 3 0.0001
860 PERITONITIS 2 0.0001
861 DIARRHOEA 62 0.0001
862 BLOOD GLUCOSE INCREASED 18 0.0001
863 DERMATITIS 2 0.0001
864 AGITATION 7 0.0001
865 PAIN IN EXTREMITY 28 0.0001
866 NEUROPATHY PERIPHERAL 9 0.0001
867 CYSTITIS 3 0.0001
868 URINARY TRACT INFECTION 16 0.0001
869 ABDOMINAL PAIN UPPER 19 0.0001
870 MELAENA 2 0.0001
871 OEDEMA PERIPHERAL 11 0.0001
872 URINARY RETENTION 3 0.0001
873 HEPATOTOXICITY 2 0.0001
874 PNEUMONIA 29 0.0001
875 PANCYTOPENIA 5 0.0001
876 THROMBOCYTOPENIA 10 0.0001
877 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
878 LETHARGY 5 0.0001
879 SOMNOLENCE 17 0.0001
880 CATARACT 5 0.0001
881 FEELING ABNORMAL 20 0.0001
882 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
883 MALAISE 36 0.0001
884 ACCIDENTAL OVERDOSE 3 0.0001
885 FALL 27 0.0001
886 BRONCHITIS 6 0.0001
887 OSTEONECROSIS OF JAW 2 0.0001
888 INFLUENZA 9 0.0001
889 COVID-19 14 0.0001
890 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
891 CARDIOVASCULAR DISORDER 2 0.0001
892 DEEP VEIN THROMBOSIS 5 0.0001
893 PLASMA CELL MYELOMA 3 0.0001
894 DEAFNESS 2 0.0001
895 ECZEMA 4 0.0001
896 JOINT SWELLING 9 0.0001
897 PRODUCT USE ISSUE 14 0.0001
898 PAIN OF SKIN 2 0.0001
899 DRUG EFFECT DECREASED 4 0.0001
900 FREQUENT BOWEL MOVEMENTS 2 0.0001
901 DRY MOUTH 6 0.0001
902 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
903 LIMB INJURY 2 0.0001
904 BLINDNESS 3 0.0001
905 HAEMATOCHEZIA 4 0.0001
906 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
907 EYE PAIN 4 0.0001
908 HYPOACUSIS 3 0.0001
909 DYSSTASIA 2 0.0001
910 MUSCULOSKELETAL STIFFNESS 6 0.0001
911 ILLNESS 7 0.0001
912 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
913 FATIGUE 52 0.0001
914 HOT FLUSH 5 0.0001
915 ALOPECIA 13 0.0001
916 STOMATITIS 4 0.0001
917 VISION BLURRED 9 0.0001
918 SKIN IRRITATION 3 0.0001
919 NEPHROLITHIASIS 3 0.0001
920 VISUAL IMPAIRMENT 8 0.0001
921 RENAL DISORDER 3 0.0001
922 BLOOD CHOLESTEROL INCREASED 3 0.0001
923 CARDIAC DISORDER 6 0.0001
924 DRUG-INDUCED LIVER INJURY 2 0.0001
925 BLOOD GLUCOSE DECREASED 3 0.0001
926 MOVEMENT DISORDER 2 0.0001
927 INFECTION 9 0.0001
928 INTERSTITIAL LUNG DISEASE 3 0.0001
929 HYPOGLYCAEMIA 3 0.0001
930 DEPRESSION 14 0.0001
931 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
932 LUNG DISORDER 3 0.0001
933 DRY EYE 3 0.0001
934 FUNGAL INFECTION 2 0.0001
935 MUSCLE SPASMS 11 0.0001
936 AGGRESSION 3 0.0001
937 NEOPLASM MALIGNANT 4 0.0001
938 GAIT INABILITY 2 0.0001
939 BALANCE DISORDER 5 0.0001
940 INJECTION SITE ERYTHEMA 7 0.0001
941 INJECTION SITE PAIN 17 0.0001
942 INJECTION SITE MASS 2 0.0001
943 ARTHROPATHY 3 0.0001
944 ABDOMINAL DISCOMFORT 9 0.0001
945 WEIGHT INCREASED 12 0.0001
946 EPISTAXIS 4 0.0001
947 DIABETES MELLITUS 4 0.0001
948 MIGRAINE 5 0.0001
949 DRUG INTOLERANCE 5 0.0001
950 DYSKINESIA 2 0.0000
951 SINUSITIS 5 0.0000
952 LUNG NEOPLASM MALIGNANT 2 0.0000
953 CONDITION AGGRAVATED 14 0.0000
954 DEVICE DISLOCATION 2 0.0000
955 MENTAL DISORDER 2 0.0000
956 INTENTIONAL PRODUCT MISUSE 4 0.0000
957 INSOMNIA 12 0.0000
958 INJECTION SITE PRURITUS 3 0.0000
959 ADVERSE DRUG REACTION 4 0.0000
960 DRUG INEFFECTIVE 57 0.0000
961 COGNITIVE DISORDER 2 0.0000
962 ARRHYTHMIA 2 0.0000
963 OVERDOSE 9 0.0000
964 UNDERDOSE 3 0.0000
965 DYSGEUSIA 3 0.0000
966 LEUKOPENIA 2 0.0000
967 FLUID RETENTION 2 0.0000
968 INFLAMMATION 2 0.0000
969 PSORIASIS 5 0.0000
970 DERMATITIS ATOPIC 2 0.0000
971 DRUG DEPENDENCE 6 0.0000
972 PROSTATE CANCER 3 0.0000
973 DISTURBANCE IN ATTENTION 2 0.0000
974 NEUTROPENIA 5 0.0000
975 MEMORY IMPAIRMENT 5 0.0000
976 DRUG ABUSE 3 0.0000
977 DEATH 31 0.0000
978 TOXICITY TO VARIOUS AGENTS 6 0.0000
979 FLATULENCE 2 0.0000
980 HERPES ZOSTER 2 0.0000
981 BLADDER CANCER 2 0.0000
982 DISEASE PROGRESSION 4 0.0000
983 NASOPHARYNGITIS 6 0.0000
984 DRY SKIN 4 0.0000
985 DEVICE MALFUNCTION 2 0.0000
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
987 ASTHMA 3 0.0000
988 HALLUCINATION 2 0.0000
989 INJECTION SITE HAEMORRHAGE 2 0.0000
990 PRODUCT DOSE OMISSION ISSUE 7 0.0000
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
992 HOSPITALISATION 3 0.0000